Search

RISK LEVEL STRATIFICATION USING CIRCULATING TUMOR DNA IN HEAD AND NECK CANCER PATIENTS

Cancer Biology

Liyona Kampel, MD, PhD; Sara Davidova, MD; Shlomo Zuriel, PhD; Narin Carmel Neiderman, MD; Dov Hershkovitz, MD, PhD; Nidal Muhanna, MD, PhD

Tel Aviv Sourasky Medical Center

EVEROLIMUS INHIBITS P53 MUTANT HNSCC BY MODULATING ANGIOGENESIS AND LYMPHANGIOGENESIS MECHANISMS LINKED TO MTOR/HIF1A/VEGF SIGNALING

Cancer Biology

Janmaris Marin Fermin; Md Maksudul Alam, PhD; Kyle A Boudreaux, MS, IV; Landon D Goodreau; Taylor L Powell; Tara Moore-Medlin; Xiaohua Rong; Jerry McLarty; Xin Gu; Cherie-Ann O Nathan

LSU-Health Shreveport

RADIATION IMPROVES THE THERAPEUTIC ANTIBODY DELIVERY IN HEAD AND NECK CANCERS.

Cancer Biology

Laura Freeman, MD; Guolan Lu, PhD; Eben Rosenthal

Stanford

CHARACTERIZING THE TUMOR MICROENVIRONMENT OF IMMUNOSUPPRESSED CUTANEOUS SQUAMOUS CELL CARCINOMA

Cancer Biology

Mica Glaun, MD¹; Frederico Gleber-Netto, PhD¹; Priyadharsini Nagarajan, MD¹; Tongxin Xie¹; Jennifer Covello¹; Shamima Akhter¹; Adebayo Adewale¹; Erez Baruch¹; Michael Wong¹; Kenneth Tsai²; Elsa Flores²; Michael Migden¹; Deborah Silverman¹; Ryan Goepfert¹; Yejing Ge¹; Padamanee Sharma¹; James Allison¹; Jeffrey Myers¹; Neil Gross¹; Moran Amit¹

¹MD Anderson Cancer Center; ²Moffitt Cancer Center

NEUTROPHIL TO LYMPHOCYTE RATIO AND PERIPHERAL BLOOD BIOMARKERS CORRELATE WITH OUTCOMES AMONG PATIENTS WITH RECURRENT METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA AND SALIVARY GLAND CANCER TREATED ON A PHASE II TRIAL OF PEMBROLIZUMAB AND VORINOSTAT

Immunotherapy / Systemic Therapy

Cassie Pan¹; Qian (Vicky) Wu²; Jenna Voutsinas²; Jeffrey J Houlton¹; Brittany Barber¹; Neal Futran¹; Renato G Martins³; Jonathan R Fromm⁴; Cristina P Rodriguez³

¹Department of Otolaryngology, University of Washington, Seattle, WA; ²Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ³Division of Oncology, Department of Medicine, University of Washington, Seattle, WA; ⁴Department of Laboratory Medicine, University of Washington, Seattle, WA

MASS SPECTROMETRY IMAGING OF THE METABOLIC LANDSCAPE OF HUMAN PAPILLOMAVIRUS-ASSOCIATED VERSUS CARCINOGEN-DRIVEN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Cancer Biology

Richard A Harbison, MD¹; William Andrews²; Rajeev Pandey¹; Rebecca Dempsey¹; Rajarsi Mandal¹; Robert Casero¹; Drew Pardoll¹; Carole Fakhry¹; Maureen Kane²; Jonathan Powell¹; Erika Pearce¹

¹Johns Hopkins Hospital; ²University of Maryland

5-AMINOLEVULINIC ACID FLUORESCENCE-GUIDED SURGERY IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: A PILOT TRIAL

Cancer Engineering / Technology

Peter Filip; David Lerner; Katherine Liu; Evan Kominsky; Brandon Gold; Annie Arrighi-Allisan; David Campbell; Mohemmed N Khan; Scott Roof; Constantinos Hadjipanayis; Eric Genden; Alfred Marc Iloreta

Icahn School of Medicine at Mount Sinai